Biological Safety Cabinet Market by Type (Class I, Class II [Type A, Type B, Type C1], Class III), End User (Pharma & Biopharma Organization, Clinical Laboratories, Academic & Biomedical Research Institutes, Others), and Region - Global Forecast to 2031

Market Size
$0.26B
MARKET SIZE, 2026
Projected Market Size
$0.36B
MARKET SIZE, 2031
CAGR
6.6%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

BIOLOGICAL SAFETY CABINET MARKET SIZE, SHARE & GROWTH SNAPSHOT

biological-safety-cabinet-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global biological safety cabinet market is projected to grow from USD 0.26 billion in 2026 to USD 0.36 billion by 2031, at a CAGR of 6.6% during the forecast period. The market was valued at USD 0.25 billion in 2025. Market growth is driven by increasing investments in pharmaceutical and biopharmaceutical research, expansion of clinical and academic laboratory infrastructure, and growing requirements for safe handling of infectious and potentially hazardous biological materials. The increasing adoption of Class II biological safety cabinets, laboratory modernization, replacement of aging equipment, and development of biologics, cell and gene therapies, and other advanced research applications are further supporting demand.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 0.25 Billion
    Current Market Size (2026): USD 0.26 Billion
    Forecast Market Size (2031): USD 0.36 Billion
    CAGR (2026–2031): 6.6%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America is expected to account for the largest share of 39.0% of the biological safety cabinet market in 2025. The US is the major contributor to regional demand.
    Type Leader: Class III is expected to register the highest CAGR during the forecast period.
    End User Leader: Pharma & biopharma organizations accounted for the largest market share of 44.4% in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Esco Lifesciences (Singapore), Labconco Corporation (US), The Baker Company (US), Kewaunee Scientific Corporation (US), and Thermo Fisher Scientific Inc. (US) were identified as star players, supported by their strong market presence and extensive product portfolios.
    Germfree Laboratories (US), Cruma (Spain), LaboGene (Denmark), Biolab Scientific (Canada), and FASTER S.r.l. (Italy) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.

The biological safety cabinet market is experiencing steady growth due to increasing investments in pharmaceutical and biopharmaceutical research, expansion of clinical and academic laboratory infrastructure, and growing requirements for safe handling of infectious and potentially hazardous biological materials. Increasing adoption of advanced containment systems, laboratory modernization, replacement of aging equipment, and greater emphasis on biosafety and contamination control are supporting market growth. Additionally, technological advancements in airflow control, HEPA filtration, energy efficiency, digital monitoring, and ergonomic cabinet design are improving laboratory safety and operational efficiency.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The influence of clinical and technological trends on the biological safety cabinet market is driven by the growing emphasis on laboratory biosafety, contamination control, and safe handling of infectious and potentially hazardous biological materials. Key applications include pharmaceutical and biopharmaceutical research, clinical diagnostics, microbiology, cell culture, infectious disease research, and academic biomedical studies. Major trends shaping the market include increasing adoption of class II biological safety cabinets, advanced HEPA filtration, automated airflow control, real-time performance monitoring, energy-efficient operation, and ergonomic cabinet designs, which enhance containment, laboratory safety, and operational efficiency.

biological-safety-cabinet-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising pharmaceutical and biopharmaceutical R&D activities
  • Rapid growth in biologics, cell and gene therapies
RESTRAINTS
Impact
Level
  • Availability of alternative containment cabinets
  • High acquisition and installation costs
OPPORTUNITIES
Impact
Level
  • Growth opportunities in emerging economies
  • Development of smart and connected biological safety cabinets
CHALLENGES
Impact
Level
  • Stringent and evolving regulatory requirements across regions
  • Shortage of qualified service and maintenance personnel

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising pharmaceutical and biopharmaceutical R&D activities

The expansion of pharmaceutical and biopharmaceutical R&D activities is increasing demand for biological safety cabinets across drug discovery, biologics development, vaccine research, cell and gene therapy, and microbiological applications. Growing laboratory capacity and the need for personnel, product, and environmental protection when handling biological materials are supporting new installations and replacement demand. Class II cabinets are particularly important because they provide these three levels of protection and are widely used across laboratory applications.

Restraint: High acquisition and installation costs

High upfront costs associated with biological safety cabinets, including equipment procurement, laboratory modifications, ventilation or exhaust requirements, installation, certification, and decontamination, can constrain adoption, particularly among smaller laboratories and institutions with limited capital budgets. The need for specialized installation and periodic certification can further increase the total cost of ownership.

Opportunity: Development of smart and connected biological safety cabinets

The development of smart and connected biological safety cabinets presents an opportunity for manufacturers to differentiate products through automated airflow monitoring, digital controls, performance alerts, filter monitoring, data logging, and remote diagnostics. Integration of these capabilities can improve operational visibility, support preventive maintenance, and enhance laboratory safety while reducing manual monitoring requirements.

Challenge: Stringent and evolving regulatory requirements across regions

Compliance with differing biosafety, certification, installation, and performance requirements across countries can increase product-development complexity and time-to-market. In the US, NSF/ANSI 49 establishes requirements for the design, construction, performance, installation, and certification of class II biological safety cabinets, while manufacturers serving international markets must address additional regional standards and requirements. Maintaining certification and adapting products to evolving regulatory expectations can increase compliance costs.

BIOLOGICAL SAFETY CABINET MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides Class II Type A2 containment for applications requiring personnel and product protection, including cell culture, clinical research, life science research, microbiology, and healthcare applications Provides personnel and product protection | Supports contamination control | Enables airflow and filter monitoring | Improves laboratory safety and workflow efficiency
company logo
Designed for handling pathogenic biological samples and applications requiring a sterile work zone, with Class II containment providing operator, product, and environmental protection Provides personnel, product, and environmental protection | Supports contamination control | Enables energy-efficient operation | Provides continuous airflow monitoring and operational safety
company logo
Designed for laboratory applications involving hazardous particulates, including biological research, cell culture, genetic material, and selected pharmaceutical applications | The cabinet can operate with recirculated HEPA-filtered air or optional canopy-connected exhaust Provides personnel, product, and environmental protection | Supports controlled laboratory environments | Enables flexible exhaust configurations | Supports safe handling of biological and hazardous materials
company logo
Provides containment for clinical, pharmaceutical, life science, and research laboratory applications requiring personnel, product, and environmental protection Provides personnel, product, and environmental protection | Supports stable containment through automated airflow control | Reduces energy consumption | Supports extended filter life and workflow continuity
company logo
Provides configurable Class II Type A2 containment for research, clinical, pharmaceutical, and biotechnology laboratory applications, with configurations supporting different geographic and certification requirements Provides personnel, product, and environmental protection | Supports continuous containment monitoring | Enables flexible laboratory configurations | Supports pharmaceutical, clinical, and biotechnology applications

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The biological safety cabinet ecosystem comprises manufacturers, distributors, pharmaceutical and biopharmaceutical organizations, clinical laboratories, academic and biomedical research institutes, and other end users, each contributing to the adoption and use of containment equipment. Manufacturers develop and commercialize class I, class II, and class III biological safety cabinets, along with HEPA filtration, airflow-control, monitoring, and other containment technologies for applications involving biological and potentially hazardous materials. Distributors support product availability, installation, certification, and after-sales services across regional markets. End users, including pharmaceutical and biopharmaceutical organizations, clinical laboratories, and academic and biomedical research institutes, utilize these cabinets for microbiological testing, cell culture, infectious disease research, drug development, quality control, and other laboratory applications requiring personnel, product, and environmental protection.

biological-safety-cabinet-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

biological-safety-cabinet-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Biological Safety Cabinet Market, By Type

From 2026 to 2031, the class III segment is expected to register the highest CAGR in the biological safety cabinet market. This growth is primarily supported by increasing demand for high-containment laboratory environments for handling highly hazardous biological agents, infectious materials, and specialized pharmaceutical and biopharmaceutical applications. Growing investments in advanced biosafety infrastructure and high-containment research facilities are further supporting adoption of Class III cabinets.

Biological Safety Cabinet Market, by End User

In 2025, the pharma & biopharma organizations segment accounted for the largest share of the biological safety cabinet market and is expected to maintain its leading position through 2026. This is primarily driven by extensive use of biological safety cabinets in drug discovery, biologics development, vaccine research, cell and gene therapy, quality control, and other pharmaceutical and biopharmaceutical laboratory activities. Expanding R&D facilities and increasing requirements for controlled containment during the handling of biological materials are further supporting demand from this end-user segment.

REGION

Asia Pacific to be fastest-growing region in global biological safety cabinet market during forecast period

Asia Pacific is expected to register the highest CAGR in the biological safety cabinet market from 2026 to 2031, driven by expanding pharmaceutical and biopharmaceutical R&D, increasing laboratory infrastructure, and rising investments in biotechnology and clinical research. Countries such as China, India, Japan, and South Korea are witnessing continued investments in laboratory modernization, biopharmaceutical manufacturing, and advanced research facilities. The growing emphasis on laboratory biosafety, infectious disease research, cell-based therapies, and safe handling of biological materials is further supporting demand for biological safety cabinets across the region. In addition, increasing adoption of Class II cabinets, particularly Type A2, along with replacement of aging laboratory equipment and expansion of diagnostic and research facilities, is expected to accelerate regional market growth.

biological-safety-cabinet-market Region

BIOLOGICAL SAFETY CABINET MARKET: COMPANY EVALUATION MATRIX

In the biological safety cabinet market, Thermo Fisher Scientific Inc. (US) is recognized as a Star player, supported by its established portfolio of Class II biological safety cabinets, broad laboratory presence, and extensive distribution network. Its Thermo Scientific 1300 Series Class II Type A2 cabinets provide personnel and product protection, with features including SmartFlow airflow control, Digital Airflow Verification, H14 HEPA filtration, and energy-efficient operation. In contrast, FASTER S.r.l. (Italy) is an emerging leader, supported by its broad portfolio of Class I, Class II, and Class III biological safety cabinets and established presence across pharmaceutical, biotechnology, microbiology, diagnostics, and research applications.

biological-safety-cabinet-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.25 Billion
Market Size in 2026 (Value) USD 0.26 Billion
Market Forecast in 2031 (Value) USD 0.36 Billion
Growth Rate CAGR of 6.6 % from 2026–2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Type:
    • Class I
    • Class II
    • Class III
  • By End User:
    • Pharma & Biopharma Organizations
    • Clinical Laboratories
    • Academic & Biomedical Research Institutes
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: BIOLOGICAL SAFETY CABINET MARKET REPORT CONTENT GUIDE

biological-safety-cabinet-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Country-wise analysis of the biological safety cabinet market across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa Delivered detailed country-level market sizing, growth forecasts, and demand analysis across major regions, with assessment of pharmaceutical and biopharmaceutical R&D, laboratory infrastructure, biosafety requirements, product adoption, and demand across Class I, Class II, and Class III cabinets Incorporated country-specific analysis of pharmaceutical and biotechnology activity, research infrastructure, biosafety regulations, laboratory investments, infectious disease research, and demand for containment equipment to identify high-growth markets and investment opportunities
Market share analysis and competitive benchmarking of key biological safety cabinet companies
  • Provided detailed competitive benchmarking and market positioning of leading BSC players based on product portfolio, Class I/II/III offerings, geographic presence, distribution reach, certification capabilities, technological features, and strategic initiatives
  • Key participants include Thermo Fisher Scientific, Esco Lifesciences, Labconco, The Baker Company, Kewaunee Scientific, FASTER, and other regional manufacturers
Expanded the competitive landscape by profiling established and emerging players and assessing product launches, acquisitions, partnerships, geographic expansion, airflow and filtration innovations, energy-efficiency initiatives, and smart-monitoring capabilities to evaluate future competitive positioning
Pricing analysis of biological safety cabinets Delivered country-wise pricing analysis of biological safety cabinets, including Class I, Class II Type A1/A2/B1/B2/C1, and Class III cabinets, with pricing variations assessed by cabinet configuration, size, certification, airflow technology, filtration system, and supplier Incorporated country-level analysis of installation and certification requirements, distributor margins, laboratory procurement practices, customization, after-sales service, and replacement cycles to provide a comprehensive assessment of pricing trends and market accessibility across regions

RECENT DEVELOPMENTS

  • January 2026 : Labconco Corporation (US) launched the Prism Class II, Type A2 Biosafety Cabinet, expanding its biosafety cabinet portfolio with a cabinet designed for personnel, product, and environmental protection. The product incorporated Constant Airflow Profile (CAP) technology, real-time alerts, a touchscreen interface, and an ergonomic design to support safe and efficient laboratory workflows.
  • January 2025 : Biobase Group (China) launched a radiation protection biosafety cabinet, expanding its containment-equipment portfolio for applications requiring biological and radiation protection. The product combined biosafety containment with radiation-protection features to address specialized laboratory requirements.
  • August 2024 : Labconco Corporation (US) launched its redesigned Logic Biosafety Cabinet, featuring an updated operating system, touchscreen interface, improved airflow management, and enhanced ergonomic features. The redesigned cabinet was intended to improve laboratory safety and workflow efficiency while reducing energy consumption and operating noise.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
24
2
EXECUTIVE SUMMARY
 
 
 
 
 
28
3
PREMIUM INSIGHTS
 
 
 
 
 
33
4
MARKET OVERVIEW
Explore booming biopharmaceutical growth driving investment in biosafety and emerging market opportunities.
 
 
 
 
 
35
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
GROWING BIOLOGICAL DEVELOPMENT AND BIOPHARMACEUTICAL ACTIVITY
 
 
 
 
 
 
4.2.1.2
INCREASING INVESTMENTS IN LABORATORY INFRASTRUCTURE
 
 
 
 
 
 
4.2.1.3
RISING EMPHASIS ON LABORATORY BIOSAFETY AND CONTAMINATION CONTROL
 
 
 
 
 
 
4.2.1.4
PERSISTENT BURDEN OF INFECTIOUS DISEASES AND PATHOGENIC AGENTS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH INSTALLATION, CERTIFICATION, AND MAINTENANCE REQUIREMENTS
 
 
 
 
 
 
4.2.2.2
HIGH COST OF BIOLOGICAL SAFETY CABINETS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
GROWTH OPPORTUNITIES IN EMERGING MARKETS
 
 
 
 
 
 
4.2.3.2
TECHNOLOGICAL ADVANCEMENTS IN BIOLOGICAL SAFETY CABINETS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
SHORTAGE OF SKILLED PERSONNEL FOR BSC CERTIFICATION AND MAINTENANCE
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
Navigate evolving industry dynamics with strategic insights into competitive forces and macroeconomic shifts.
 
 
 
 
 
45
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
BIOLOGICAL SAFETY CABINET MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE, BY KEY PLAYER, 2024–2026
 
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE, BY REGION, 2024–2026
 
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 8414.70)
 
 
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 8414.70)
 
 
 
 
 
5.8
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.10
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFFS—BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON REGIONS
 
 
 
 
 
 
 
5.11.4.1
NORTH AMERICA
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
 
 
 
 
 
 
5.11.5.2
CLINICAL LABORATORIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI innovations and patents reshape biological safety cabinets, unlocking new market potentials.
 
 
 
 
 
61
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
HEPA FILTRATION
 
 
 
 
 
 
6.1.2
AIRFLOW & CONTAINMENT CONTROL
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
DECONTAMINATION TECHNOLOGY
 
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
LABORATORY ENVIRONMENTAL MONITORING SYSTEMS
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
LIST OF MAJOR PATENTS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
6.7
IMPACT OF AI/GENERATIVE AI ON BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
 
 
6.7.1
INTRODUCTION
 
 
 
 
 
 
6.7.2
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.7.3
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
 
 
6.7.4
FUTURE OF AI/GEN AI
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate global compliance and eco-friendly innovations driving biological safety cabinet sustainability.
 
 
 
 
 
69
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.2.1
ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN BIOLOGICAL SAFETY CABINET
 
 
 
 
 
 
 
7.2.1.1
ECO-FRIENDLY INITIATIVES
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Identify unmet needs and optimize stakeholder influence to unlock market profitability and margin opportunities.
 
 
 
 
 
73
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
 
8.5.1
REVENUE POTENTIAL
 
 
 
 
 
 
8.5.2
COST DYNAMICS
 
 
 
 
 
 
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
 
 
 
 
9
BIOLOGICAL SAFETY CABINET MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
80
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
CLASS I
 
 
 
 
 
 
 
9.2.1
BASIC CONTAINMENT REQUIREMENTS SUSTAIN CLASS I CABINET DEMAND
 
 
 
 
 
9.3
CLASS II
 
 
 
 
 
 
 
9.3.1
CLASS II TYPE A
 
 
 
 
 
 
 
9.3.1.1
CLASS II TYPE A1
 
 
 
 
 
 
 
 
9.3.1.1.1
ESTABLISHED LABORATORY INSTALLATIONS MAINTAIN TYPE A1 DEMAND
 
 
 
 
9.3.1.2
CLASS II TYPE A2
 
 
 
 
 
 
 
 
9.3.1.2.1
BROAD BIOLOGICAL WORKFLOWS DRIVE TYPE A2 DEMAND
 
 
 
9.3.2
CLASS II TYPE B
 
 
 
 
 
 
 
9.3.2.1
CLASS II TYPE B1
 
 
 
 
 
 
 
 
9.3.2.1.1
SPECIALIZED CHEMICAL-BIOLOGICAL APPLICATIONS SUPPORT TYPE B1 DEMAND
 
 
 
 
9.3.2.2
CLASS II TYPE B2
 
 
 
 
 
 
 
 
9.3.2.2.1
TOTAL-EXHAUST REQUIREMENTS SUPPORT SPECIALIZED TYPE B2 DEMAND
 
 
 
9.3.3
CLASS II TYPE C1
 
 
 
 
 
 
 
9.3.3.1
FLEXIBLE EXHAUST CONFIGURATIONS CREATE A DIFFERENTIATED TYPE C1 NICHE
 
 
 
 
9.4
CLASS III
 
 
 
 
 
 
 
9.4.1
MAXIMUM-CONTAINMENT REQUIREMENTS SUPPORT CLASS III CABINET DEMAND
 
 
 
 
10
BIOLOGICAL SAFETY CABINET MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 17 Data Tables
 
 
 
 
 
100
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
PHARMA & BIOPHARMA ORGANIZATIONS
 
 
 
 
 
 
 
10.2.1
RISING BIOLOGICS DEVELOPMENT AND R&D INVESTMENT TO DRIVE HIGH-END BSC ADOPTION
 
 
 
 
 
10.3
CLINICAL LABORATORIES
 
 
 
 
 
 
 
10.3.1
RISING DISEASE BURDEN AND DIAGNOSTIC TESTING VOLUMES TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.4
ACADEMIC & BIOMEDICAL RESEARCH INSTITUTES
 
 
 
 
 
 
 
10.4.1
SUSTAINED RESEARCH FUNDING TO SHAPE MARKET GROWTH
 
 
 
 
 
10.5
OTHER END USERS
 
 
 
 
 
11
BIOLOGICAL SAFETY CABINET MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 10 Countries | 93 Data Tables.
 
 
 
 
 
109
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
NORTH AMERICA
 
 
 
 
 
 
 
11.2.1
US
 
 
 
 
 
 
 
11.2.1.1
GROWTH IN BIOSIMILARS MARKET TO BOOST PRECLINICAL RESEARCH
 
 
 
 
 
11.2.2
CANADA
 
 
 
 
 
 
 
11.2.2.1
GOVERNMENT SUPPORT FOR R&D TO SUPPORT MARKET GROWTH
 
 
 
 
11.3
EUROPE
 
 
 
 
 
 
 
11.3.1
GERMANY
 
 
 
 
 
 
 
11.3.1.1
INCREASED PHARMACEUTICAL R&D AND BIOMANUFACTURING INVESTMENTS TO DRIVE MARKET GROWTH
 
 
 
 
 
11.3.2
UK
 
 
 
 
 
 
 
11.3.2.1
EXPANDING BIOPHARMACEUTICAL R&D TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.3.3
FRANCE
 
 
 
 
 
 
 
11.3.3.1
EXPANSION OF BIOPHARMACEUTICAL MANUFACTURING TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.3.4
ITALY
 
 
 
 
 
 
 
11.3.4.1
EXPANSION OF BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.3.5
SPAIN
 
 
 
 
 
 
 
11.3.5.1
EXPANSION OF BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.3.6
REST OF EUROPE
 
 
 
 
 
11.4
ASIA PACIFIC
 
 
 
 
 
 
 
11.4.1
CHINA
 
 
 
 
 
 
 
11.4.1.1
GOVERNMENT SUPPORT FOR INNOVATIVE DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.4.2
JAPAN
 
 
 
 
 
 
 
11.4.2.1
STRONG ACADEMIC–INDUSTRY COLLABORATION TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.4.3
INDIA
 
 
 
 
 
 
 
11.4.3.1
EXPANSION OF BIOTECHNOLOGY RESEARCH AND BIOMANUFACTURING TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.4.4
REST OF ASIA PACIFIC
 
 
 
 
 
11.5
LATIN AMERICA
 
 
 
 
 
 
 
11.5.1
EXPANSION OF PHARMACEUTICAL R&D AND CLINICAL RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
11.6.1
INCREASING CLINICAL RESEARCH AND BIOTECHNOLOGY ACTIVITIES TO DRIVE MARKET GROWTH
 
 
 
 
12
COMPETITIVE LANDSCAPE
Uncover strategic shifts and market dominance in the biological safety cabinet industry by 2025.
 
 
 
 
 
150
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
12.2.1
OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
12.3
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
12.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
 
12.4.1
GLOBAL MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
12.5.1
STARS
 
 
 
 
 
 
12.5.2
EMERGING LEADERS
 
 
 
 
 
 
12.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
12.5.4
PARTICIPANTS
 
 
 
 
 
 
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
12.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
12.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
12.5.5.3
TYPE FOOTPRINT
 
 
 
 
 
 
12.5.5.4
END-USER FOOTPRINT
 
 
 
 
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
12.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
12.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
12.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
12.6.4
STARTING BLOCKS
 
 
 
 
 
 
12.6.5
COMPANY FOOTPRINT: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
12.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
12.7.1
FINANCIAL METRICS
 
 
 
 
 
 
12.7.2
COMPANY VALUATION
 
 
 
 
 
12.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
12.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
12.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
 
 
 
 
 
 
12.9.2
DEALS
 
 
 
 
 
 
12.9.3
EXPANSIONS
 
 
 
 
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
166
 
13.1
KEY PLAYERS
 
 
 
 
 
 
 
13.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
13.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
13.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
13.1.1.3
MNM VIEW
 
 
 
 
 
 
 
 
13.1.1.3.1
RIGHT TO WIN
 
 
 
 
 
 
13.1.1.3.2
STRATEGIC CHOICES
 
 
 
 
 
 
13.1.1.3.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
13.1.2
KEWAUNEE SCIENTIFIC CORPORATION
 
 
 
 
 
 
13.1.3
ESCO LIFESCIENCES GROUP
 
 
 
 
 
 
13.1.4
LABCONCO CORPORATION
 
 
 
 
 
 
13.1.5
THE BAKER COMPANY, INC.
 
 
 
 
 
 
13.1.6
GERMFREE LABORATORIES, INC.
 
 
 
 
 
 
13.1.7
CRUMA
 
 
 
 
 
 
13.1.8
AIR SCIENCE USA LLC
 
 
 
 
 
 
13.1.9
BERNER INTERNATIONAL GMBH
 
 
 
 
 
 
13.1.10
LABOGENE
 
 
 
 
 
 
13.1.11
BIOLAB SCIENTIFIC LTD.
 
 
 
 
 
 
13.1.12
LAMSYSTEMS CC
 
 
 
 
 
13.2
OTHER PLAYERS
 
 
 
 
 
 
 
13.2.1
FASTER S.R.L.
 
 
 
 
 
 
13.2.2
BIOBASE GROUP
 
 
 
 
 
 
13.2.3
THERMOLAB SCIENTIFIC EQUIPMENTS PVT. LTD.
 
 
 
 
 
 
13.2.4
LABMATE SCIENTIFIC LLC
 
 
 
 
 
 
13.2.5
TOPAIR SYSTEMS INC.
 
 
 
 
 
 
13.2.6
ZHEJIANG FUXIA MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
 
 
13.2.7
BIONICS SCIENTIFIC
 
 
 
 
 
 
13.2.8
SCITEK GLOBAL CO., LTD.
 
 
 
 
 
 
13.2.9
HEAL FORCE BIO-MEDITECH HOLDINGS LIMITED
 
 
 
 
 
 
13.2.10
SHANGHAI BOXUN MEDICAL BIOLOGICAL INSTRUMENT CORP.
 
 
 
 
 
 
13.2.11
HAIER BIOMEDICAL
 
 
 
 
 
 
13.2.12
HMC EUROPE GMBH
 
 
 
 
 
 
13.2.13
NORDIC LABTECH AB
 
 
 
 
14
RESEARCH METHODOLOGY
 
 
 
 
 
201
 
14.1
RESEARCH DATA
 
 
 
 
 
 
14.2
RESEARCH APPROACH
 
 
 
 
 
 
 
14.2.1
SECONDARY DATA
 
 
 
 
 
 
 
14.2.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
14.2.2
PRIMARY DATA
 
 
 
 
 
 
 
14.2.2.1
LIST OF PRIMARY SOURCES
 
 
 
 
 
 
14.2.2.2
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
14.2.2.3
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
14.2.2.4
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
14.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
14.3.1
TOTAL MARKET SIZE: BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
14.3.2
BOTTOM-UP APPROACH
 
 
 
 
 
 
 
14.3.2.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
 
 
14.3.2.2
APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
 
 
 
 
 
 
14.3.2.3
GROWTH FORECAST
 
 
 
 
 
 
14.3.2.4
CAGR PROJECTIONS
 
 
 
 
 
14.3.3
TOP-DOWN APPROACH
 
 
 
 
 
14.4
DATA TRIANGULATION
 
 
 
 
 
 
14.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
 
14.5.1
STUDY-RELATED ASSUMPTIONS
 
 
 
 
 
14.6
STUDY ASSUMPTIONS
 
 
 
 
 
 
 
14.6.1
PARAMETRIC ASSUMPTIONS
 
 
 
 
 
 
14.6.2
GROWTH RATE ASSUMPTIONS
 
 
 
 
 
14.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
14.8
RISK ASSESSMENT
 
 
 
 
 
15
APPENDIX
 
 
 
 
 
212
 
15.1
DISCUSSION GUIDE
 
 
 
 
 
 
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
15.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
15.4
RELATED REPORTS
 
 
 
 
 
 
15.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
BIOLOGICAL SAFETY CABINET MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 2
GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
 
 
 
 
 
 
TABLE 3
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 4
EUROPE: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 5
ASIA PACIFIC: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 6
LATIN AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 7
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 8
AVERAGE SELLING PRICE OF BIOLOGICAL SAFETY CABINET PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 9
AVERAGE SELLING PRICE OF BIOLOGICAL SAFETY CABINET PRODUCTS, BY REGION, 2024–2026 (USD)
 
 
 
 
 
 
TABLE 10
IMPORT DATA FOR HS CODE 8414.70-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 11
EXPORT DATA FOR HS CODE 8414.70-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 12
BIOLOGICAL SAFETY CABINET MARKET: MAJOR CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 13
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 14
KEY PATENTS IN BIOLOGICAL SAFETY CABINET MARKET, 2022–2026
 
 
 
 
 
 
TABLE 15
KEY COMPANIES IMPLEMENTING AI IN BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
TABLE 16
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOLOGICAL SAFETY CABINET PRODUCTS, BY TYPE (%)
 
 
 
 
 
 
TABLE 22
KEY BUYING CRITERIA FOR BIOLOGICAL SAFETY CABINETS, BY TYPE
 
 
 
 
 
 
TABLE 23
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
TABLE 24
BIOLOGICAL SAFETY CABINET MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
TABLE 25
BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 26
CLASS I BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
NORTH AMERICA: CLASS I BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
EUROPE: CLASS I BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
ASIA PACIFIC: CLASS I BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
NORTH AMERICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
EUROPE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
ASIA PACIFIC: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
NORTH AMERICA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
EUROPE: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
ASIA PACIFIC: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
CLASS II TYPE A1 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
NORTH AMERICA: CLASS II TYPE A1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
EUROPE: CLASS II TYPE A1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
ASIA PACIFIC: CLASS II TYPE A1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
CLASS II TYPE A2 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NORTH AMERICA: CLASS II TYPE A2 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
EUROPE: CLASS II TYPE A2 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
ASIA PACIFIC: CLASS II TYPE A2 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
NORTH AMERICA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
EUROPE: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
ASIA PACIFIC: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
CLASS II TYPE B1 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
NORTH AMERICA: CLASS II TYPE B1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
EUROPE: CLASS II TYPE B1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
ASIA PACIFIC: CLASS II TYPE B1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
CLASS II TYPE B2 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
NORTH AMERICA: CLASS II TYPE B2 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
EUROPE: CLASS II TYPE B2 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
ASIA PACIFIC: CLASS II TYPE B2 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
CLASS II TYPE C1 BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
NORTH AMERICA: CLASS II TYPE C1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
EUROPE: CLASS II TYPE C1 BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
CLASS III BIOLOGICAL SAFETY CABINETS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
NORTH AMERICA: CLASS III BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
EUROPE: CLASS III BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
ASIA PACIFIC: CLASS III BIOLOGICAL SAFETY CABINETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
BIOLOGICAL SAFETY CABINET MARKET FOR PHARMA & BIOPHARMA ORGANIZATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET FOR PHARMA & BIOPHARMA ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
EUROPE: BIOLOGICAL SAFETY CABINET MARKET FOR PHARMA & BIOPHARMA ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET FOR PHARMA & BIOPHARMA ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
BIOLOGICAL SAFETY CABINET MARKET FOR CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
EUROPE: BIOLOGICAL SAFETY CABINET MARKET CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
BIOLOGICAL SAFETY CABINET MARKET FOR ACADEMIC & BIOMEDICAL RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET FOR ACADEMIC & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
EUROPE: BIOLOGICAL SAFETY CABINET MARKET FOR ACADEMIC & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET FOR ACADEMIC & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
BIOLOGICAL SAFETY CABINET MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
EUROPE: BIOLOGICAL SAFETY CABINET MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
BIOLOGICAL SAFETY CABINET MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 87
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
NORTH AMERICA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
US BIOLOGICAL SAFETY CABINET MARKET VOLUME, 2024–2031 (UNITS)
 
 
 
 
 
 
TABLE 94
US: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
US: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
US: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
US: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
US: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
CANADA: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
CANADA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
CANADA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
CANADA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
CANADA: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
EUROPE: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 105
EUROPE: BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
EUROPE: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
EUROPE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
EUROPE: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EUROPE: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
EUROPE: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
GERMANY: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
GERMANY: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
GERMANY: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
GERMANY: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
GERMANY: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
UK: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
UK: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
UK: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
UK: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
UK: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
FRANCE: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
FRANCE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
FRANCE: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
FRANCE: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
FRANCE: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
ITALY: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
ITALY: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
ITALY: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
ITALY: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
ITALY: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
SPAIN: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
SPAIN: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
SPAIN: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
SPAIN: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
SPAIN: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
REST OF EUROPE: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
REST OF EUROPE: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
REST OF EUROPE: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
REST OF EUROPE: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
REST OF EUROPE: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
ASIA PACIFIC: MACROECONOMIC INDICATORS
 
 
 
 
 
 
TABLE 142
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
ASIA PACIFIC: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
ASIA PACIFIC: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
ASIA PACIFIC: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
CHINA: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
CHINA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
CHINA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
CHINA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
CHINA: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
JAPAN: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
JAPAN: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
JAPAN: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
JAPAN: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
JAPAN: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
INDIA: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
INDIA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
INDIA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
INDIA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
INDIA: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
REST OF ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
REST OF ASIA PACIFIC: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
REST OF ASIA PACIFIC: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
REST OF ASIA PACIFIC: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
REST OF ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
LATIN AMERICA: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
LATIN AMERICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
LATIN AMERICA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
LATIN AMERICA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
LATIN AMERICA: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
MIDDLE EAST & AFRICA: BIOLOGICAL SAFETY CABINET MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
MIDDLE EAST & AFRICA: CLASS II BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
MIDDLE EAST & AFRICA: CLASS II TYPE A BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
MIDDLE EAST & AFRICA: CLASS II TYPE B BIOLOGICAL SAFETY CABINETS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
MIDDLE EAST & AFRICA: BIOLOGICAL SAFETY CABINET MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BIOLOGICAL SAFETY CABINET MARKET, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 179
BIOLOGICAL SAFETY CABINET MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 180
BIOLOGICAL SAFETY CABINET MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 181
BIOLOGICAL SAFETY CABINET MARKET: TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 182
BIOLOGICAL SAFETY CABINET MARKET: END USER FOOTPRINT
 
 
 
 
 
 
TABLE 183
BIOLOGICAL SAFETY CABINET MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 184
BIOLOGICAL SAFETY CABINET MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 185
BIOLOGICAL SAFETY CABINET MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 186
BIOLOGICAL SAFETY CABINET MARKET: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 187
BIOLOGICAL SAFETY CABINET MARKET: EXPANSION, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 188
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 189
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 190
KEWAUNEE SCIENTIFIC CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 191
KEWAUNEE SCIENTIFIC CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 192
KEWAUNEE SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 193
ESCO LIFESCIENCES GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 194
ESCO LIFESCIENCES GROUP: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 195
ESCO LIFESCIENCES GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 196
ESCO LIFESCIENCES GROUP: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 197
ESCO LIFESCIENCES GROUP: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 198
LABCONCO CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 199
LABCONCO CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 200
LABCONCO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 201
THE BAKER COMPANY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 202
THE BAKER COMPANY, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 203
THE BAKER COMPANY, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 204
GERMFREE LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 205
GERMFREE LABORATORIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 206
CRUMA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 207
CRUMA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 208
AIR SCIENCE USA LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 209
AIR SCIENCE USA LLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 210
BERNER INTERNATIONAL GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 211
BERNER INTERNATIONAL GMBH: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 212
LABOGENE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 213
LABOGENE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 214
BIOLAB SCIENTIFIC LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 215
BIOLAB SCIENTIFIC LTD.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 216
LAMSYSTEMS CC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 217
LAMSYSTEMS CC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 218
BIOLOGICAL SAFETY CABINET MARKET: RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
KEY INSIGHTS AND MARKET HIGHLIGHTS
 
 
 
 
 
 
FIGURE 3
GLOBAL BIOLOGICAL SAFETY CABINET MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOLOGICAL SAFETY CABINET MARKET, 2023–2025
 
 
 
 
 
 
FIGURE 5
DISRUPTIVE TRENDS IMPACTING GROWTH OF BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
FIGURE 6
HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN BIOLOGICAL SAFETY CABINET MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 8
INCREASING INVESTMENTS IN LABORATORY INFRASTRUCTURE AND BIOSAFETY TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 9
CLASS II SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
PHARMA & BIOPHARMA ORGANIZATIONS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
BIOLOGICAL SAFETY CABINET MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 13
BIOLOGICAL SAFETY CABINET MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 14
BIOLOGICAL SAFETY CABINET MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 15
BIOLOGICAL SAFETY CABINET MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 16
BIOLOGICAL SAFETY CABINET MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 17
BIOLOGICAL SAFETY CABINET MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 18
NUMBER OF DEALS & FUNDING ACTIVITIES IN BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
FIGURE 19
PATENT ANALYSIS FOR BIOLOGICAL SAFETY CABINETS, JANUARY 2016–DECEMBER 2025
 
 
 
 
 
 
FIGURE 20
MARKET POTENTIAL OF AI IN BIOLOGICAL SAFETY CABINET MARKET
 
 
 
 
 
 
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOLOGICAL SAFETY CABINET PRODUCTS, BY TYPE
 
 
 
 
 
 
FIGURE 22
KEY BUYING CRITERIA FOR BIOLOGICAL SAFETY CABINETS, BY TYPE
 
 
 
 
 
 
FIGURE 23
NORTH AMERICA: BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 24
ASIA PACIFIC: BIOLOGICAL SAFETY CABINET MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 25
REVENUE ANALYSIS OF KEY PLAYERS IN BIOLOGICAL SAFETY CABINET MARKET, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 26
BIOLOGICAL SAFETY CABINET MARKET SHARE ANALYSIS, 2025 (GLOBAL)
 
 
 
 
 
 
FIGURE 27
BIOLOGICAL SAFETY CABINET MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 28
BIOLOGICAL SAFETY CABINET MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 29
BIOLOGICAL SAFETY CABINET MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 30
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 31
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 32
BIOLOGICAL SAFETY CABINET MARKET: PRODUCT COMPARISON FOR BIOLOGICAL SAFETY CABINET
 
 
 
 
 
 
FIGURE 33
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 34
KEWAUNEE SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 35
BIOLOGICAL SAFETY CABINET MARKET: RESEARCH DESIGN METHODOLOGY
 
 
 
 
 
 
FIGURE 36
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 37
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
 
 
FIGURE 38
BIOLOGICAL SAFETY CABINET MARKET: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 39
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study will examine the competitive landscape of the biological safety cabinets market by evaluating market participants based on various criteria within the overarching categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

Biological Safety Cabinet Market 
 Size, and Share

Note: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenue figures were calculated using revenue mapping for major product manufacturers and OEMs active in the global biological safety cabinets market. All major product manufacturers were identified at the global and/or country-/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Additionally, the global market was split into various segments and subsegments:

  • List of major players in the biological safety cabinets market by region or country
  • Product mapping of various biological safety cabinets manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from biological safety cabinets products (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
  • Summation of revenue of all companies to arrive at the global biological safety cabinets market size

The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Biological Safety Cabinet Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall size of the global biological safety cabinets market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market-related data was triangulated by studying various macro indicators and regional trends from demand- and supply-side participants.

Market Definition

Biological safety cabinets (BSCs) are enclosed containment devices equipped with HEPA filters that provide controlled protection for personnel, the environment, and biological samples from exposure to biohazardous agents during laboratory procedures. They are widely used in laboratories handling infectious, potentially infectious, or other hazardous biological materials.

Key Stakeholders

  • Government and private research institutes
  • Manufacturers and suppliers of biological safety cabinets
  • Pharmaceutical and biopharmaceutical companies
  • Academic research institutes
  • Venture capitalists
  • Medical research centers
  • Research and consulting firms

Report Objectives

  • To describe, segment, and forecast the biological safety cabinets market, by type and end user, in terms of value
  • To forecast the size of the biological safety cabinets market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
  • To provide detailed information about the factors (drivers, restraints, opportunities, and challenges) influencing market growth
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall biological safety cabinets market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the key players in the biological safety cabinets market and comprehensively analyze their core competencies and market shares
  • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the market
  • To benchmark players within the biological safety cabinets market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available customizations:

Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:

GEOGRAPHIC ANALYSIS

  • Further breakdown of the Rest of European biological safety cabinets market into Russia, Switzerland, Denmark, Austria, and others
  • Further breakdown of the Rest of Asia Pacific biological safety cabinets market into Hong Kong, Taiwan, and others
  • Further breakdown of the Rest of Latin American biological safety cabinets market into Argentina, Colombia, Chile, Ecuador, and others
  • Further breakdown of the Southeast Asian biological safety cabinets market into Malaysia, Singapore, Australia, New Zealand, and others

COMPETITIVE LANDSCAPE ASSESSMENT

  • Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the biological safety cabinets market
  • Competitive leadership mapping for established players in the US

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biological Safety Cabinet Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Biological Safety Cabinet Market

DMCA.com Protection Status
popup img